COMMUNIQUÉS West-GlobeNewswire

-
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
19/07/2024 -
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
19/07/2024 -
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
19/07/2024 -
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
19/07/2024 -
Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation
19/07/2024 -
Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la compatibilité de ses appareils avec les examens IRM corps entier et de leur conformité aux exigences du règlement de l’Union européenne sur les dispositifs médicaux
19/07/2024 -
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
19/07/2024 -
Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la conformité de la thérapie Inspire aux exigences du règlement de l’Union européenne sur les dispositifs médicaux
19/07/2024 -
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19/07/2024 -
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product
19/07/2024 -
SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC
19/07/2024 -
Augmedix to Join Forces with Commure
19/07/2024 -
Nicox announces attendance at upcoming conferences
19/07/2024 -
Nicox : Participation aux prochaines conférences
19/07/2024 -
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
19/07/2024 -
Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease
18/07/2024 -
Appili Therapeutics Announces Second Amendment to Arrangement Agreement
18/07/2024 -
Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation
18/07/2024 -
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
18/07/2024
Pages